- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05787782
Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts
October 29, 2025 updated by: Masimo Corporation
This is a prospective, non-randomized data collection study to evaluate the performance of the Masimo INVSENSOR00063 in obtaining temperature measurements.
Study Overview
Detailed Description
Individual sites are only representative of a subset of the overall population, per ISO 80601-2-56:2017(Medical electrical equipment - Part 2-56: Particular requirements for basic safety and essential performance of clinical thermometers for body temperature measurement), and therefore clinical bias and limits of agreement should not be evaluated for the subsets.
Publication of results should include repeatability from individual sites and the combined clinical bias and limits of agreement (NCT05787782, NCT05674344 and NCT05779397).
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Fullerton, California, United States, 92835
- Ascada Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Participant age ≥ 1 year
- Afebrile or febrile at time of enrollment: For febrile subjects, ≥ 99.5 F/ 37.5 C for sublingual temperature reference; ≥ 100.4 F/ 38 C for temporal artery temperature reference.
- English-or Spanish-speaking patient or parent/Legal Guardian
Exclusion Criteria:
- Participants deemed not suitable for the study at the discretion of the investigator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Masimo INVSENSOR00063
All subjects are enrolled into this arm and will have temperature measurements obtained.
|
Masimo INVSENSOR00063 will be used to measure temperature
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of Temperature Measurements Using Masimo INVSENSOR00063
Time Frame: About 15-30 minutes
|
Masimo INVSENSOR00063 temperature measurements will be compared to reference temperature measurements.
Accuracy of Masimo INVSENSOR00063 will be measured using clinical bias, limits of agreement and repeatability.
|
About 15-30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 23, 2023
Primary Completion (Actual)
March 2, 2023
Study Completion (Actual)
March 2, 2023
Study Registration Dates
First Submitted
March 15, 2023
First Submitted That Met QC Criteria
March 15, 2023
First Posted (Actual)
March 28, 2023
Study Record Updates
Last Update Posted (Estimated)
October 31, 2025
Last Update Submitted That Met QC Criteria
October 29, 2025
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KOEI0004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fever
-
Centre Hospitalier Annecy GenevoisNot yet recruitingEmergency Call | Fever; Pediatric Fever Management; Parental AnxietyFrance
-
Karolinska InstitutetCompletedCrimean Congo Hemorrhagic FeverSweden
-
Chengdu Jinjiang Maternity and Child Health HospitalNot yet recruiting
-
Meir Medical CenterCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedYellow Fever | Dengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Liverpool School of Tropical MedicineMedical Research Council; MEDEX; Mologic LtdNot yet recruitingCrimean-Congo Haemorrhagic Fever
-
Shaare Zedek Medical CenterCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedDengue Fever | Dengue Hemorrhagic FeverSingapore
-
U.S. Army Medical Research and Development CommandBausch Health Americas, Inc.WithdrawnCrimean-Congo Hemorrhagic Fever | Lassa FeverGermany
Clinical Trials on Masimo INVSENSOR00063
-
Masimo CorporationRecruiting
-
Masimo CorporationCompletedHealthyUnited States
-
Hvidovre University HospitalUnknownCOVID-19 | Respiratory FailureDenmark
-
Masimo CorporationCompleted
-
Masimo CorporationCompletedHealthy | Atrial FibrillationUnited States
-
Shaare Zedek Medical CenterUnknown
-
Children's Hospital of PhiladelphiaChildren's Anesthesiology Associates, Ltd.CompletedScoliosis | Spinal FusionUnited States
-
Masimo CorporationCompleted
-
The Cleveland ClinicRecruitingPregnancy Related | Congenital Heart Disease | Congenital Cardiomyopathy | Congenital Vascular DisorderUnited States
-
Masimo CorporationCompleted